PharmAI – Industry Is Smartening Up To Potential Of Artificial Intelligence
Exploring Pharma Deal-Making For AI And Machine Learning Technologies
Executive Summary
AstraZeneca’s pact with the UK-based artificial intelligence leader BenevolentAI, in April 2019, is one component in a string of recent deals that have highlighted big pharma’s desire to embed AI and machine learning within the R&D process. In total, 13 such collaborations have been tracked in the past 24 months, according to the Strategic Transactions database.
You may also be interested in...
'Touchless Plants' To Virtually Trained Workforces - Indian Cos Share Digitalization Tips
Despite AI and digital analytics playing an increasing role in pharma, the industry lags others globally, a recent event heard. Meanwhile, top Indian players including Sun Pharma, Cipla and others shared what is driving their initiatives, ranging from a 'touchless factory' to virtual training and lessons learned along the way.
The Bigger Picture And Global Innovation Hotspots
Focusing too much on the US provides a blinkered view of the industry and prevents access to the myriad opportunities on offer globally.
Managing Lifecycles Amid Stifling Competition
Biopharma is entering a new period of intense competition from new sources, requiring a change in approach to portfolio strategy and lifecycle management.